Back
Merus NV Vs. Intra-Cellular Therapies Industry Stock Comparison
Buy
74
MRUS
Merus NV
Last Price:
56.50
Seasonality Move:
6.15%
Sell
45
ITCI
Intra-Cellular Therapies
Last Price:
67.73
Seasonality Move:
11.34%
Buy
74
Merus NV (MRUS)
is a Buy
Is Merus NV a Buy, Sell or Hold?
- The current Merus NV [MRUS] share price is $56.55. The Score for MRUS is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- MRUS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy, Sell or Hold?
- The current Intra-Cellular Therapies [ITCI] share price is $67.77. The Score for ITCI is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- ITCI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MRUS Stock Price Chart
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $67.77
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITCI is experiencing slight selling pressure.
MRUS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.72 | Buy |
| Relative Strength Index (14 RSI): | 60.79 | Buy |
| Chaikin Money Flow: | -65155 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.2 - 56.18) | Buy |
| Bollinger Bands (100): | (39.85 - 50.89) | Buy |
ITCI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.07 | Buy |
| Relative Strength Index (14 RSI): | 49.13 | Sell |
| Chaikin Money Flow: | -73805 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (65.75 - 68.29) | Buy |
| Bollinger Bands (100): | (65.84 - 71.9) | Sell |
MRUS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.05 | Buy |
| 20-day SMA: | 52.09 | Buy |
| 50-day SMA: | 47.26 | Buy |
| 200-day SMA: | 35.05 | Buy |
| 8-day EMA: | 55.4 | Buy |
| 20-day EMA: | 52.74 | Buy |
| 50-day EMA: | 48.89 | Buy |
| 200-day EMA: | 38.23 | Buy |
ITCI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 68.41 | Sell |
| 20-day SMA: | 67.26 | Buy |
| 50-day SMA: | 68.9 | Sell |
| 200-day SMA: | 63.76 | Buy |
| 8-day EMA: | 68.17 | Sell |
| 20-day EMA: | 67.9 | Sell |
| 50-day EMA: | 68.17 | Sell |
| 200-day EMA: | 65.13 | Buy |
Merus NV Earnings Growth & MRUS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.24 per share, and a decrease next year of $0.33 per share.
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.01 per share, an increase this year of $1.11 per share, and an increase next year of $1.43 per share.
Merus NV Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Intra-Cellular Therapies Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||